Beck Capital Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-11,877
Closed -$1.54M – 106
2023
Q4
$1.54M Buy
11,877
+4,482
+61% +$618K 0.53% 72
2023
Q3
$1.21M Sell
7,395
-868
-11% -$153K 0.46% 77
2023
Q2
$1.51M Buy
8,263
+136
+2% +$19.6K 0.6% 69
2023
Q1
$1.08M Buy
+8,127
New +$955K 0.46% 82
2022
Q4
– Sell
-22,650
Closed -$1.37M – 125
2022
Q3
$1.37M Buy
+22,650
New +$1.46M 0.59% 73

Other funds holding ACLS

Beck Capital Management's ACLS Position: Q1 2024 in Review

Beck Capital Management sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 11,877 shares — an estimated $1.54M sold.

Beck Capital Management first reported a position in ACLS in Q3 2022 and held it in 5 quarters. The position peaked at $1.54M in Q4 2023. 386 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

  • Beck Capital Management reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
  • Beck Capital Management sold 11,877 Axcelis shares in Q1 2024, an estimated $1.54M.
  • Beck Capital Management first reported a position in Axcelis in Q3 2022 and held it in 5 quarters.
  • Beck Capital Management's Axcelis position peaked at $1.54M in Q4 2023.
  • 386 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on Beck Capital Management's 13F filing for Q1 2024, filed 15 May 2024.